Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEMA Fentanyl for breakthrough cancer pain
NCT00293033Phase 3Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Feb 2006
- Primary completion
- Apr 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by BioDelivery Sciences International. Started Feb 2006; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00293033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293033.